Filing Details

Accession Number:
0001008310-12-000006
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-07 17:23:21
Reporting Period:
2012-02-03
Filing Date:
2012-02-07
Accepted Time:
2012-02-07 17:23:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899923 Myriad Genetics Inc MYGN In Vitro & In Vivo Diagnostic Substances (2835) 870494517
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1008310 D Peter Meldrum 320 Wakara Way
Salt Lake City UT 84108
President & C.e.o. Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-02-03 35,000 $12.64 215,921 No 4 M Direct
Common Stock Disposition 2012-02-03 35,000 $23.97 180,921 No 4 S Direct
Common Stock Acquisiton 2012-02-06 18,222 $12.64 199,143 No 4 M Direct
Common Stock Disposition 2012-02-06 18,222 $23.96 180,921 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-02-03 35,000 $0.00 35,000 $12.64
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-02-06 18,222 $0.00 18,222 $12.64
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
34,998 2012-02-22 No 4 M Direct
16,776 2012-02-22 No 4 M Direct
Footnotes
  1. The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.